Novavax (NVAX) Price to Sales (2011 - 2026)
Novavax's Price to Sales was 3.75 in Q2 2026, up 296.2% from 0.95 a year earlier and up 67.2% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Price to Sales at Novavax came in at 0.97, down 48.6% from FY2024.
- In earlier years, Price to Sales was 1.89 in FY2024 (+284.5%), 0.49 in FY2023 (+10.2%), 0.45 in FY2022 (-95.3%) and 9.47 in FY2021 (-29.9%).
- The Q2 2026 figure marks the highest quarterly Price to Sales since Q1 2022.
- Compared with a year earlier, Price to Sales was higher in five of the last eight quarters, with growth averaging 101.2%.
- The best year-over-year quarter for Price to Sales over five years was Q2 2024 (growth of 367.2%); the worst was Q4 2022 (a decline of 95.3%).
- Per Business Quant data, NVAX's Price to Sales in the three quarters before Q2 2026 was 2.24 (Q1 2026), 0.97 (Q4 2025) and 1.32 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Novavax | 1.72 Bn | -1.28 Bn | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.75 |
| Mar 31, 2026 | 2.24 |
| Dec 31, 2025 | 0.97 |
| Sep 30, 2025 | 1.32 |
| Jun 30, 2025 | 0.95 |
| Mar 31, 2025 | 0.83 |
| Dec 31, 2024 | 1.89 |
| Sep 30, 2024 | 2.29 |
| Jun 30, 2024 | 2.05 |
| Mar 31, 2024 | 0.67 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.44 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.77 |
| Jun 30, 2022 | 3.11 |
| Mar 31, 2022 | 4.10 |
| Dec 31, 2021 | 9.47 |
| Sep 30, 2021 | 12.99 |
API Access
Novavax Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();